NCT06469801Recruiting
ECMO ABI Detection With Hyperfine
Low-Field Bedside MRI for Detection of Acute Brain Injury in Pediatric Extracorporeal Membrane Oxygenation
Source: ClinicalTrials.gov · Last updated 24 Sept 2026
Brief summary (registry, in English)
The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 12 Jun 2024
- Start date
- 23 Jul 2024
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Diseases
- Stroke
- NCT number
- NCT06469801
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 23 Jul 2024 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a passive or active implant will:
- First be reviewed on MRISafety.com to determine MR conditionality
- If device is listed as Conditional or Unsafe for a 1.5T or a 3T, device will then be reviewed by MRI Safety Officer or MRI Physician Section chief to determine true conditionality for the portable MRI
Other
- Pregnancy
- Any patient who has a contraindication to having an MRI
Who the study is looking for
- Participants that will be or are admitted to the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit
- Ages 0-17 years
- Participants that are at high risk for undergoing ECMO or are currently undergoing venovenous or venoarterial ECMO
- High risk participants include, but are not limited to:
- Undergoing cardiac surgery
- Congenital heart disease
- Congenital diaphragmatic hernia
- Refractory hypoxemic and/or hypercarbic respiratory failure
- Vasoactive-refractory shock
Age in the registry: 0 days to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Mercy Coordinator of this site? Confirm its status | Kansas City | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.